Various species of Streptomyces possess aminoglycoside-modifying enzymes. Streptomyces kanamyceticus contains an enzyme that acetylates the 6'-amino group of kanamycin A and B, gentamicin Cla, and neomycin. Streptomyces spectabilis produces an enzyme that acetylates the 2'-amino group of the hexose ring of gentamicin Cia. These enzymes catalyze reactions identical to those catalyzed by enzymes found in gram-negative bacteria containing R(antibiotic resistance)-factors. The discovery of these enzymes suggests the possibility of an evolutionary relationship between the aminoglycosideinactivating enzymes (produced by resistance determinants) in bacteria containing R-factors and similar enzymes found in the actinomycetes.
Resistance to antibiotics in clinical isolates of gram-negative and gram-positive bacteria is usually mediated by the presence of various enzymes that modify the antibiotic so that it can no longer interact with its target in the cell. The f3-lactamases hydrolyze the penicillins and cephalosporins, chloramphenicol acetyltransferase acetylates chloramphenicol, and nine enzymes acetylate, phosphorylate, or adenylylate the aminoglycoside antibiotics (1, 2) . The genetic loci coding for these enzymes are usually located on extrachromosomal elements, such as the R(antibiotic resistance)-factors in gram-negative bacteria. Since these genes are not normal chromosomal components of the resistant strains, there has been considerable speculation as to their origin. Walker and Walker (3) have suggested that some R-factors might have originated in organisms that produce antibiotics.
Molecular studies have shown that R-factors consist of two parts that are reversibly dissociable, these are the resistance transfer factor (RTF), and the r-determinants, genes that determine resistance to antibiotics (2) . Watanabe (4) has suggested that the r-determinants exist somewhere in nature as chromosomal genes and that they are "picked-up" by promiscuous RTFs to form R-factors. The question is, where do the r-determinants originate?
We have initiated a search in the actinomycetes for aminoglycoside-modifying enzymes like those that have been characterized in strains carrying R-factors (R+) in the belief that this might represent the r-determinant gene pool. The actinomycetes are a group of organisms that have been considered to be intermediate between bacteria and fungi, but Abbreviations: R-factor, antibiotic resistance factor; R +, containing R-factor. * Present address: Viral Leukemia and Lymphoma Branch, National Cancer Institute, Bethesda, Md. 20014 t To whom correspondence should be addressed. their cellular dimensions, their cytology, and their genetics place them among the bacteria (5, 6) . One of the most striking properties of the actinomycetes is the extent to which they produce antibiotics; most of the aminoglycoside antibiotics (streptomycin, neomycin, kanamycin, gentamicin, tobramycin, and lividomycin) are produced by them.
Enzymes that modify other antibiotics have been isolated from Streptomyces species; in studies on the biosynthesis of streptomycin in Streptomyces bikiniensis, Miller and Walker (3, 8) and Nimi and coworkers (9, 10) found three enzymes that phosphorylated streptomycin. In addition, Argoudelis and Coats have reported the presence of enzymes that phosphorylate lincomycin and clindamycin (11) , adenylylate clindamycin (12) , and acetylate chloramphenicol (13) .
MATERIALS AND METHODS
Growth of Strains. Strains were started from a spore inoculum and grown with vigorous agitation on a rotary shaker at 30°for 4-6 days, until the beginning of stationary phase.
Micromonospora purpurea was first grown at 370 for 3 days, and then a 1:20 dilution of this culture was made into fresh medium and incubated at 300. Cultures were monitored every 12 hr for pH, mycelial dry weight, and antibiotic production, and were checked for contaminants microscopically and by streaking on appropriate media before harvesting. S. 
RESULTS
Identification of Antibiotics Produced by the Actinomycetes. The aminoglycoside antibiotic-inactivating enzymes currently known to exist in antibiotic-resistant bacteria, are listed in Table 1 , and the antibiotics that they modify are shown in Table 2 . For a review of the properties and substrate specificities of these enzymes, see ref. 1 . The actinomycetes were grown from a spore inoculum in either synthetic or complex medium as described in Methods. To verify the identity of the antibiotics produced by the actinomycetes, we tested supernatant medium from cultures in stationary phase as substrate for four of the aminoglycoside-inactivating enzymes: kanamycin-acetyltransferase, neomycin-kanamycin phosphotransferase I, streptomycin phosphotransferase, and streptomycin-spectinomycin adenylyltransferase. Since the substrate specificities of these enzymes are known (Table 2) , the identity of the antibiotics produced by the various actinomycetes could be easily verified. The supernatant from the S. spectabilis medium served as substrate for streptomycin-spectinomycin adenylyltransferase, and not for streptomycin phosphotransferase, as would be expected if spectinomycin were being produced. S. kanamyceticus produced kanamycin, a substrate for kanamycin acetyltransferase and neomycin phosphotransferase, and M. purpurea produced gentamicin, a substrate for kanamycin acetyltransferase. The use of gentamicin adenylyltransferase could have distinguished between neomycin and kanamycin, since only the latter is a substrate. The S. coelicolor supernatant contained no detectable antibiotic (no substrate activity with any of the four enzymes). Thus, the antibiotic-inactivating enzymes have analytical applications, as has been demonstrated in the use of certain enzymes for the rapid analysis of antibiotic concentration in serum (14) (15) (16) (17) and 3-N-acetyl gentamicin Cia [acetylated on the 3-amino group of 2-deoxystreptamine by a gentamicin-resistant strain of Psudomonas-see Fig. 2 (18) ], it was decided to study the gentamicin-acetylating enzymes from S. spectabilis and S. kanamyceticus in more detail. The gentamicin-acetylating activity of S. coelicolor was not further studied.
Acetylation of Aminoglycosides in S. spectabilis. The crude S. spectabilis extract was found to acetylate a wide variety of aminoglycosides. To determine if this was due to the presence of more than one enzyme, the extract was fractionated by passage through a DEAE-cellulose column with a linear gradient of sodium chloride, as described (17) . Only one peak of acetylating activity for all the aminoglycosides tested could be found; this activity eluted at 0.21 M NaCl. The enzyme has a pH optimum of 5.3, which is the same regardless of the substrate with which the enzyme is assayed. In general, assay conditions were identical to those of kanamycin acetyltransferase (17) mycin, paromomycin, neomycin B, and kanamycin B and C.
Kanamycin A, 3-N-acetyl gentamicin Cia (18), nebramycin factor 2, streptomycin, and spectinomycin were not acetylated. The fact that kanamycin C is acetylated and kanamycin A is not strongly implies that the 2-amino moiety of that aminosugar ring is acetylated (Fig. 1) . To verify this, we acetylated gentamicin Cia in a large-scale reaction so that the product could be isolated and studied.
Large-Scale Modification of Gentamicin C1a by S. spectabilis Extract. S. spectabilis was grown in 3.5 liters of complex medium and yielded 350 g (wet weight) of cells. The cells were disrupted by passage through a French press, and the extract was used to acetylate 100 mg of gentamicin Cla in the presence of coenzyme A, magnesium acetate, and ATP.
The acetylated gentamicin C1a was purified by chromatography on a Biorex 70 column (BioRad) exactly as described for the purification of 6'-N-acetyl gentamicin Cla (17) . Two peaks of radioactivity were obtained, which by analogy with previous work (17) were believed to contain mono-and diacetylated gentamicin C1a, respectively. The mono-acetylated gentamicin Cia was shown to be pure by the same techniques that were used for 6'-N-acetyl gentamicin Cia (17) .
Dr. Peter Daniels has characterized this mono-acetylated gentamicin Cia by mass spectroscopy and has shown it to have the characteristic fragmentation pattern of 2'-N-acetylgentamicin Cia (Fig. 2) (19) . The diacetate has not been characterized. Acetylation of Aminoglycosides in S. kanamyceticus. A crude S. kanamyceticus extract was fractionated by chromatography on DEAE-cellulose, and the acetylating activity eluted at 0.17 M NaCl. The enzyme has a pH optimum of 7.4 for the acetylation of gentamicin Cia, paromomycin, and kanamycin B. The list of substrates acetylated by this extract includes gentamicin Cia, gentamicin A, sisomicin, kanamycin A, B, and C, tobramycin, neomycin B, and paromomycin. Streptomycin, spectinomycin, and nebramycin factor 2 are not acetylated.
Large-Scale Modification of Gentamicin Cla by the S. kanamyceticus Extract. For determination of the site of acetylation of gentamicin Cla, 60 mg of this antibiotic was acetylated as described in Methods. A small amount of gentamicin Cla was also acetylated with ['4C]acetyl coenzyme A of high specific activity in order to monitor the elution of the compound during purification. When this mixture was chromatographed on Biorex 70, the same elution profile as that obtained after the S. spectabilis reaction was seen.
The mono-acetylated gentamicin Cla has been analyzed chemically and spectrographically, and shown to be 6'-Nacetyl gentamicin Cla (Fig. 2) . Since kanamycin C and paromomycin do not contain a 6-amino moiety but are acetylated by this extract, there must be an additional acetylating enzyme in the S. kanamyceticus extract. DISCUSSION We report the presence of enzymes in actinomycetes that can modify certain of the aminoglycoside antibiotics.
Two acetylated gentamicin derivatives had already been characterized from R+ Escherichia coli and Pseudomonas aeruginosa (17, 18) , so it was decided to study the gentamicin Cia-acetylating enzymes that were discovered in S. spectabilis spectabilis acetylated gentamicin C1a on the 2'-amino group of the purpurosamine ring, and the enzyme from S. kanamyceticus produced 6'-N-acetyl gentamicin Cla.
Thus, one of the aminoglycoside-modifying enzymes discovered in Streptomyces appears to catalyze the same reaction as an enzyme that has previously been described in R+ E. coli, namely kanamycin acetyltransferase. Since these experiments were performed, an enzyme has been found in a clinical isolate of a Providencia strain that catalyzes a reaction identical to that of gentamicin acetyltransferase II discovered first in S. spectabilis (Chevereau, Daniels, Davies, and LeGoffic, in preparation).
We have also detected streptomycin-phosphorylating activity in S. griseus, a streptomycin-producing actinomycete; this may be similar to that reported by others (3, 6-10) and has not been studied further. Studies with S. fradiae, which produces neomycin, have shown the presence of a phosphotransferase that appears to modify the 3'OH of neomycin, as is the case with neomycin-phosphorylating enzymes found in gram-negative bacteria (ref. 20 ; Dowding and Benveniste, unpublished observations). The isolation and characterization of the inactivating enzymes in an actinomycete producing a new antibiotic might presage the mechanisms of enzymatically-mediated resistance in clinical isolates resistant to the antibiotic.
The metabolic role of the aminoglycoside-modifying enzymes in actinomycetes is not known. Miller and Walker have postulated that phosphorylated streptomycin might be important as a metabolic precursor of streptomycin or to detoxify the antibiotic (7). The enzymes might also be required for transport of these antibiotics in or out of the cell. Alternatively, they may have nothing to do with antibiotic biosynthesis and may play a role in another biosynthetic process.
Whatever the role of these enzymes, the actinomycetes are a new source of aminoglycoside-modifying enzymes that could be used to provide new antibiotic derivatives with altered biological properties. Since the aminoglycoside antibiotics have undesirable toxic effects, especially when administered in high doses for prolonged periods of time, some of these modified antibiotics might combine biological activity with reduced toxicity. Examination of other strains of bacteria (including actinomycetes) will surely result in the discovery of new modifying enzymes. Bacillus circulans, which produces the novel modified aminoglycoside antibiotic butirosih, may also contain some of these enzymes. Only acetylation, phosphorylation, and adenylylation activities in a small number of strains have been examined here-it is possible that some modified aminogiycosides may be produced by other mechanisms. In addition, the enzymes described here were all isolated from strains in stationary phase; different enzymes may be present during the exponential growth of the organism, or under different culture conditions.
Nothing is known about the origin of R factors. The Watanabe hypothesis (4) provides a simple molecular mechanism for their origin, but we can only speculate on the environmental and evolutionary factors that play a role in their formation and maintenance. Their presence does not seem to require the extensive use of a selective antibiotic environment since Gardner et al. (21) have found R factors in an "antibiotic virgin population" in the Solomon Islands. These R factors, which were isolated from soil and stool specimens, and S. kanamyceticus. The acetylating enzyme from S.
Proc. Nat. Acad. Sci. USA 70 (1978) mediated resistance to streptomycin and tetracycline.
The discovery of aminoglycoside-modifying enzymes in actinomycetes catalyzing the same reactions as those found in clinical isolates of other bacteria suggests an origin for resistance determinants. The fact that identical enzymatic activities are found in two separate organisms does not necessarily imply a direct transfer of genetic information from one to the other. The actinomycetes may excrete antibiotics into the soil in order to complete effectively with other soil microorganisms for nutrients, and it could be that some gramnegative or gram-positive bacteria have acquired the inactivating enzymes in order to protect themselves against these antibiotics. Hill (22) has shown that penicillin is produced in soils inoculated with a wild-type Penicillium chrysogenum, and that Bacillus cereus strains constitutive for i3-lactamase production have a clear survival advantage in this soil.
At present we can only speculate as to the mechanism of the possible transfer of genetic information from actinomycetes to other bacteria. There is no evidence for a transduction or conjugation system capable of such a transfer, but a recent report of stable genetic transformation of E. coli by isolated R-factor DNA (23) suggests a plausible mechanism. Alternatively, genetic transfer by conjugation or transduction may have occurred through. a chain of closely related organisms, even though the initial donor and final recipient may be totally unrelated bacterial species. In any case, a more detailed comparative study of the enzymatic and immunological properties of the purified enzymes from actinomycetes and other bacteria may reveal relationships between them, unless the enzymes have evolved divergently to a great extent.
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